levorphanol

DRUG2 trials

Sponsors

University of California, San Francisco, M.D. Anderson Cancer Center

Conditions

Chronic PainHematopoietic and Lymphoid Cell NeoplasmMalignant Solid NeoplasmMetastatic Malignant Solid Neoplasm

Early Phase 1

Levorphanol as a Second Line Opioid in Reducing Pain in Patients With Cancer

TerminatedNCT03579446

M.D. Anderson Cancer CenterHematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm

Start: 2018-11-29End: 2023-06-15Updated: 2025-08-03

Unknown Phase

Evolution of Analgesic Tolerance With Opioids

CompletedNCT00275249

University of California, San FranciscoChronic Pain

Start: 2001-03-31End: 2005-12-31Target: 60Updated: 2011-04-14

Related Papers

Evolution of Analgesic Tolerance and Opioid-Induced Hyperalgesia Over 6 Months: Double-Blind Randomized Trial Incorporating Experimental Pain Models.

2020-02-0112 citations